Trial intelligence / Profile preview

PADIS-TVP: 18 Months Warfarin vs Placebo for Idiopathic Proximal DVT

NCT00740493Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Brest
Start
Jul 2007
Primary completion
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of warfarin in venous thromboembolism (VTE), deep vein thrombosis (DVT), sponsored by Centre Hospitalier Universitaire de Brest. Started Jul 2007; status: completed.

02

Drugs

warfarin
03

Conditions

venous thromboembolism (VTE)deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT00740493.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00740493.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call